Insights

Inhibitory DNA reduced tumor cell malignancy in rats by inducing tRNA methylase inhibitors. Removing the DNA restored tumor-producing capacity, highlighting DNA's role in cancer virulence.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Walker-256 carcinosarcoma is a well-characterized rat tumor model.
  • Tumorigenicity is a key characteristic of malignant cells.
  • DNA and its interactions can influence cellular behavior.

Purpose of the Study:

  • To investigate the effect of tumor-derived inhibitory DNA on Walker-256 carcinosarcoma cell malignancy in vitro and in vivo.
  • To explore the relationship between DNA treatment, cellular virulence, and the induction of specific enzyme inhibitors.

Main Methods:

  • Walker-256 carcinosarcoma cells were cultured in vitro with tumor-derived inhibitory DNA.
  • Cellular growth was assessed in vitro.
  • Tumorigenicity was evaluated by injecting treated cells into rats.
  • The presence of tRNA methylase inhibitors was measured in treated cells.

Main Results:

  • In vitro growth of carcinosarcoma cells was unaffected by inhibitory DNA.
  • In vivo injection of DNA-treated cells resulted in diminished tumor formation (reduced oncogenicity).
  • Treatment with inhibitory DNA led to the induction of tRNA methylase inhibitors in the malignant cells.
  • Removal of inhibitory DNA from the culture medium caused the disappearance of tRNA methylase inhibitors and the reappearance of oncogenicity.

Conclusions:

  • Tumor-derived inhibitory DNA can reduce the malignant potential of cancer cells without affecting their in vitro growth.
  • The reduction in virulence is associated with the induction of tRNA methylase inhibitors.
  • This suggests a mechanism by which specific DNA fractions can modulate cancer cell oncogenicity, offering potential therapeutic insights.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...